BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29027612)

  • 1. Penetrance of a rare familial mutation predisposing to papillary thyroid cancer.
    Saporito D; Brock P; Hampel H; Sipos J; Fernandez S; Liyanarachchi S; de la Chapelle A; Nagy R
    Fam Cancer; 2018 Jul; 17(3):431-434. PubMed ID: 29027612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Rare Variants Predisposing to Thyroid Cancer.
    Wang Y; Liyanarachchi S; Miller KE; Nieminen TT; Comiskey DF; Li W; Brock P; Symer DE; Akagi K; DeLap KE; He H; Koboldt DC; de la Chapelle A
    Thyroid; 2019 Jul; 29(7):946-955. PubMed ID: 30957677
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical behavior and genetics of nonsyndromic, familial nonmedullary thyroid cancer.
    Bauer AJ
    Front Horm Res; 2013; 41():141-8. PubMed ID: 23652675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
    Ye F; Gao H; Xiao L; Zuo Z; Liu Y; Zhao Q; Chen H; Feng W; Fu B; Sun L; Jiang X; He D; Jiang H; Yang M; Li L; Chen F; Liu X; Li S; Li Z; Jiang Y; Cheng L; Bu H
    Int J Cancer; 2019 Mar; 144(6):1321-1330. PubMed ID: 30132833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.
    Mazeh H; Benavidez J; Poehls JL; Youngwirth L; Chen H; Sippel RS
    Thyroid; 2012 Jan; 22(1):3-8. PubMed ID: 22136209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
    Canzian F; Amati P; Harach HR; Kraimps JL; Lesueur F; Barbier J; Levillain P; Romeo G; Bonneau D
    Am J Hum Genet; 1998 Dec; 63(6):1743-8. PubMed ID: 9837827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on familial nonmedullary thyroid cancer.
    Ammar SA; Alobuia WM; Kebebew E
    Endocrine; 2020 Jun; 68(3):502-507. PubMed ID: 32162184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
    Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
    Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).
    Pereira JS; da Silva JG; Tomaz RA; Pinto AE; Bugalho MJ; Leite V; Cavaco BM
    Endocrine; 2015 May; 49(1):204-14. PubMed ID: 25381600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways.
    Srivastava A; Kumar A; Giangiobbe S; Bonora E; Hemminki K; Försti A; Bandapalli OR
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31614935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.
    Cirello V; Colombo C; Karapanou O; Pogliaghi G; Persani L; Fugazzola L
    Front Endocrinol (Lausanne); 2020; 11():589340. PubMed ID: 33488516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ-line mutations in
    Zhao Y; Yu T; Sun J; Wang F; Cheng C; He S; Chen L; Xie D; Fu L; Guan X; Yan A; Li Y; Miao G; Zhu X
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries.
    Fallah M; Pukkala E; Tryggvadottir L; Olsen JH; Tretli S; Sundquist K; Hemminki K
    J Med Genet; 2013 Jun; 50(6):373-82. PubMed ID: 23585692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance.
    He H; Li W; Wu D; Nagy R; Liyanarachchi S; Akagi K; Jendrzejewski J; Jiao H; Hoag K; Wen B; Srinivas M; Waidyaratne G; Wang R; Wojcicka A; Lattimer IR; Stachlewska E; Czetwertynska M; Dlugosinska J; Gierlikowski W; Ploski R; Krawczyk M; Jazdzewski K; Kere J; Symer DE; Jin V; Wang Q; de la Chapelle A
    PLoS One; 2013; 8(5):e61920. PubMed ID: 23690926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function.
    Pires C; Marques IJ; Valério M; Saramago A; Santo PE; Santos S; Silva M; Moura MM; Matos J; Pereira T; Cabrera R; Lousa D; Leite V; Bandeiras TM; Vicente JB; Cavaco BM
    J Biol Chem; 2024 Mar; 300(3):105767. PubMed ID: 38367672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer.
    Diquigiovanni C; Bergamini C; Evangelisti C; Isidori F; Vettori A; Tiso N; Argenton F; Costanzini A; Iommarini L; Anbunathan H; Pagotto U; Repaci A; Babbi G; Casadio R; Lenaz G; Rhoden KJ; Porcelli AM; Fato R; Bowcock A; Seri M; Romeo G; Bonora E
    Int J Cancer; 2018 Oct; 143(7):1706-1719. PubMed ID: 29672841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
    Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
    Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features of familial nonmedullary thyroid carcinoma.
    Fan YF; Zhang B; Yang X; Shang ZH; Liu HF; Xie Y; Liu YW; Gao WS; Wu Q; Li XY
    Chin Med J (Engl); 2015 Apr; 128(8):1037-41. PubMed ID: 25881596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
    Zhang T; Xing M
    J Natl Cancer Inst; 2016 Jun; 108(6):djv415. PubMed ID: 26832773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Aggregation and Heritability of Nonmedullary Thyroid Cancer in an Asian Population: A Nationwide Cohort Study.
    Lin HT; Liu FC; Lin SF; Kuo CF; Chen YY; Yu HP
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32333767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.